波音游戏-波音娱乐城赌球打不开

CityUHK’s IDM establishes partnership with Korea’s Samsung Advanced Institute for Health Sciences & Technology

 

M Yang
The MoU is signed by Professor Yang (left) and Professor Chang in Seoul, Korea.

The Institute of Digital Medicine (IDM) of City University of Hong Kong (CityUHK) and the Samsung Advanced Institute for Health Sciences & Technology (SAIHST) in Korea signed a Memorandum of Understanding (MoU) in Seoul on 18 March. It aims to establish collaboration on health-related research, particularly in cell and gene therapy, bioinformatics and biomedical engineering, as well as talent development and commercialising digital health solutions to benefit society.

The MoU was signed by Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) at CityUHK, and Professor Chang Yun Sil, Director of SAIHST.

SAIHST is a leading institute, jointly established by industry – Samsung Group, a hospital – Samsung Medical Center, and academia – Sungkyunkwan University (SKKU) – to advance research and nurture professional experts to lead the future of biomedical sciences. SAIHST is Korea’s first graduate school of interdisciplinary convergence medical science to conduct healthcare-focused research and education. The institute partnered with universities and research institutes in more than 10 countries, such as the United States, Canada, the United Kingdom, France, and partnership with domestic and global pharmaceutical companies, large corporations and biotech firms.

IDM was established in April 2024. In collaboration with renowned universities and medical schools around the world, as well as clinical and industry partners and health tech investors, IDM utilises CityUHK’s research strengths in engineering, data science and life science to develop innovative technologies to explore digital health solutions, for the long-term benefit of doctors and patients.

 “Global collaboration is crucial for the development of digital medicine,” said Professor Freddy Boey, President of CityUHK. “The partnership between IDM and SAIHST marks a significant milestone in advancing health technology innovation. With CityUHK’s dynamic innovation and entrepreneurial ecosystem, I am confident that our joint efforts will empower our future leaders on the global stage and create a positive impact on Hong Kong, Korea, and beyond.”

photo1
CityUHK's IDM and the SAIHST in Korea have established collaboration to advance health-related research, and promote talent development and commercialising digital health solutions, benefiting society in the long term.

IDM and SAIHST will establish talent-nurturing collaboration with an international perspective. SAIHST will support eligible top-tier researchers and scientists by facilitating their visits to Hong Kong, participating in programmes offered by the CityUHK Academy of Innovation, and providing internship opportunities for CityUHK students.

The two parties will strengthen their partnership in health-related innovations through CityUHK’s HK Tech 300 programme, jointly transforming innovative ideas into practical applications and promoting the development of deep-tech start-ups.

Following the signing ceremony, CityUHK's IDM delegation held discussions with professors from four SAIHST departments: Health Sciences and Technology, Digital Health, Medical Device Management and Research, and Clinical Research Design and Evaluation, and shared the development of CityUHK's IDM.

YOU MAY BE INTERESTED

Contact Information

Communications and Institutional Research Office

Back to top
伟博百家乐现金网| 百家乐官网娱乐皇冠世界杯| 嘉禾百家乐的玩法技巧和规则| 肯博| 博发百家乐游戏| 新皇冠娱乐城| 百家乐一柱擎天| 百家乐官网赢足球博彩皇冠| 三星百家乐的玩法技巧和规则 | 太阳城论坛| 百家乐官网下| 互联星空棋牌中心| 百家乐注册送10彩金| 真人百家乐官网888| 全讯网777| 真人百家乐官网蓝盾娱乐场| 太阳百家乐代理| 南京百家乐官网在哪| 大发888 打法888 大发官网| 做生意门朝向什么方向| 乐百家乐官网彩现金开户| 凯时娱乐城官网| 网上百家乐打牌| 巴厘岛百家乐官网的玩法技巧和规则| 博彩太阳城| 大发888娱乐软件| 做生意适合摆放龙龟吗| 百家乐官网单跳打法| 新全讯网网站112| 百家乐官网法则| 百家乐改单| 大发888游乐场下载| 百家乐龙虎台布价格| 百家乐官网赌场代理荐| 屯昌县| 波克棋牌完整版下载| 百家乐筹码防伪定制| 百家乐官网赢的秘籍在哪| 一路发娱乐城| 大发888玩法| 百家乐中庄闲比例|